What is the official website of INTERPHEX Global ?

The official website of INTERPHEX Global is https://www.interphex.com/en-us.html#/.

What is INTERPHEX Global's cybersecurity risk score?

INTERPHEX Global has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has INTERPHEX Global experienced?

According to Rankiteo, INTERPHEX Global currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has INTERPHEX Global been affected by any supply chain cyber incidents ?

According to Rankiteo, INTERPHEX Global has been affected by multiple supply chain cyber incidents. The affected supply chain sources and their corresponding incident IDs are: Venminder (Incident ID: VENLEX1786448387) Amazon Web Services (AWS) (Incident ID: RELLEX1772562253) LexisNexis (Incident ID: LEX1772555037)

Does INTERPHEX Global have SOC 2 Type 1 certification ?

According to Rankiteo, INTERPHEX Global is not certified under SOC 2 Type 1.

Does INTERPHEX Global have SOC 2 Type 2 certification ?

According to Rankiteo, INTERPHEX Global does not hold a SOC 2 Type 2 certification.

Does INTERPHEX Global comply with GDPR ?

According to Rankiteo, INTERPHEX Global is not listed as GDPR compliant.

Does INTERPHEX Global have PCI DSS certification ?

According to Rankiteo, INTERPHEX Global does not currently maintain PCI DSS compliance.

Does INTERPHEX Global comply with HIPAA ?

According to Rankiteo, INTERPHEX Global is not compliant with HIPAA regulations.

Does INTERPHEX Global have ISO 27001 certification ?

According to Rankiteo,INTERPHEX Global is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does INTERPHEX Global operate in ?

INTERPHEX Global operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does INTERPHEX Global have ?

INTERPHEX Global employs approximately None employees people worldwide.

Does INTERPHEX Global own any subsidiaries ?

INTERPHEX Global presently has no subsidiaries across any sectors.

How many LinkedIn followers does INTERPHEX Global have ?

INTERPHEX Global's official LinkedIn profile has approximately 7,505 followers.

What is the NAICS classification code for INTERPHEX Global ?

INTERPHEX Global is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does INTERPHEX Global have a Crunchbase profile ?

No, INTERPHEX Global does not have a profile on Crunchbase.

Does INTERPHEX Global have a LinkedIn profile ?

Yes, INTERPHEX Global maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/interphex.

How many cybersecurity incidents has INTERPHEX Global experienced ?

As of September 29, 2026, Rankiteo reports that INTERPHEX Global has experienced 7 cybersecurity incidents.

How many peer or competitor companies does INTERPHEX Global have ?

INTERPHEX Global has an estimated 5,771 peer or competitor companies worldwide.

What types of cybersecurity incidents has INTERPHEX Global faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

INTERPHEX Global

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

INTERPHEX Global Vendor Cyber Rating & Cyber Score

interphex.com

Add Your Compliance Badge

Save the date to attend the leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference. April 21-23, 2025 | Javits Center, NYC RX Privacy Policy: https://privacy.rxglobal.com/

INTERPHEX Global

INTERPHEX Global CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

LexisNexis

Cyber Attack

100

8/2026

Venminder

VENLEX178644838...

LexisNexis

Breach

100

3/2026

Amazon Web Serv...

RELLEX177256225...

LexisNexis

Breach

2/2026

LexisNexis

LEX1772555037

LexisNexis

Breach

1/2026

LEX1782211793

LexisNexis

Breach

1/2025

LEX1772815548

LexisNexis

Breach

12/2024

LEX1772584112

LexisNexis

Breach

1/2020

LEX1772641919

Loading…

A.I.

INTERPHEX Global Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for INTERPHEX Global

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for INTERPHEX Global in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for INTERPHEX Global in 2026.

Incident Types INTERPHEX Global vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for INTERPHEX Global in 2026.

Incident History - INTERPHEX Global (X = Date, Y = Severity)

Loading…

SUBSIDIARY

INTERPHEX Global Subsidiaries

INTERPHEX Global

Pharmaceutical Manufacturing

Website: https://www.interphex.com/en-us.html#/

Company Size: None employees

RX USAEvents Services

Global Gaming ExpoGambling Facilities and Casinos

BuildingsNYWholesale Building Materials

PGA Golf ShowsSpectator Sports

FUNCTIONAL FABRIC FAIR (powered by PERFORMANCE DAYS)Apparel & Fashion

Loading…

INTERPHEX Global Similar Companies

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Loading…

NEWS

INTERPHEX Global CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

July 09, 2024 07:00 AM

Samsung Biologics to promote ADC capabilities at bio fair

Samsung Biologics will participate in BioPlus Interphex Korea 2024, the largest biopharmaceutical exhibition in Korea, to showcase its...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-102335

SUMMARY

Nginx Proxy Manager through 2.16.0 fails to restrict the advanced_config field to administrators, allowing non-admin users with manage permissions to inject arbitrary nginx directives. Attackers can inject malicious nginx configuration such as alias directives to serve arbitrary files or control routing for their assigned hosts.

Published

Date2026-09-28

Updated

Date2026-09-28

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-102334

SUMMARY

Nginx Proxy Manager through 2.16.0 lacks rate-limiting on authentication endpoints, allowing unauthenticated attackers to make unlimited password guesses against any account. Attackers can brute-force login credentials via POST /api/tokens and subsequently guess TOTP codes via POST /api/tokens/2fa to gain full session access and administrative control.

Published

Date2026-09-28

Updated

Date2026-09-28

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N

cvss4

Base Score: 9.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

2.2

REFERENCES

CVE-2026-102333

SUMMARY

httpdbg before 2.2.1 fails to validate URL schemes in recorded HTTP request URLs rendered as clickable links in the web interface. Attackers controlling traffic recorded by httpdbg can supply javascript: scheme URLs that execute malicious scripts in the application origin when clicked, allowing access to captured request and response data including headers and tokens.

Published

Date2026-09-28

Updated

Date2026-09-28

RISK INFORMATION (Score: 6.1)

cvss3

Base Score: 6.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.7

Exploitability

2.8

REFERENCES

CVE-2026-102332

SUMMARY

Dozzle versions before 11.1.2 fail to sanitize container display names when building ZIP archive entry names in the log download endpoint. Attackers who can label containers can use path traversal sequences to write files outside the extraction directory when users download and extract logs.

Published

Date2026-09-28

Updated

Date2026-09-28

RISK INFORMATION (Score: 6.1)

cvss3

Base Score: 6.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:C/C:N/I:H/A:N

cvss4

Base Score: 4.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:A/VC:N/VI:N/VA:N/SC:N/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

1.6

REFERENCES

CVE-2026-101262

SUMMARY

A vulnerability has been found in Ziroom ZHOME A0101 1.0.1.0. This vulnerability affects unknown code of the file /api/ZRQos/set_online_client. The manipulation of the argument ip leads to command injection. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-28

Updated

Date2026-09-28

RISK INFORMATION (Score: 9.1)

cvss2

Base Score: 8.3

Complexity: LOW

AV:N/AC:L/Au:M/C:C/I:C/A:C

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 8.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

2.3

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

INTERPHEX Global Vendor Cyber Rating & Cyber Score

INTERPHEX Global A.I CyberSecurity Scoring

INTERPHEX Global CyberSecurity News & History

INTERPHEX Global Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for INTERPHEX Global

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types INTERPHEX Global vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - INTERPHEX Global (X = Date, Y = Severity)

INTERPHEX Global Subsidiaries

INTERPHEX Global

INTERPHEX Global Similar Companies

Grifols

Dr. Reddy's Laboratories

MANKIND PHARMA LTD

Bristol Myers Squibb

Cipla

Novartis

Teva Pharmaceuticals

Sanofi

Zoetis

INTERPHEX Global CyberSecurity News

Samsung Biologics to promote ADC capabilities at bio fair

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

INTERPHEX Global CyberSecurity News & History

INTERPHEX Global Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for INTERPHEX Global

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types INTERPHEX Global vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - INTERPHEX Global (X = Date, Y = Severity)

INTERPHEX Global Subsidiaries

INTERPHEX Global

INTERPHEX Global Similar Companies

Grifols

Dr. Reddy's Laboratories

MANKIND PHARMA LTD

Bristol Myers Squibb

Cipla

Novartis

Teva Pharmaceuticals

Sanofi

Zoetis

INTERPHEX Global CyberSecurity News

Samsung Biologics to promote ADC capabilities at bio fair

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo